Ayodeji Adegunsoye, MD, MSc, PhD, FCCP
Assistant Professor of Medicine
Scientific Director, Interstitial Lung Disease Program
Committee on Clinical Pharmacology & Pharmacogenomics
Pulmonary & Critical Care
University of Chicago Medicine: Chicago, IL

Barbara Goldstein, MD, MMSc
Physician
Denver Arthritis Clinic: Denver, CO

Joshua Solomon, MD
Director, Interstitial Lung Disease Program
Professor of Medicine
Section of Critical Care Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, CO

Faculty Disclosures:

Ayodeji Adegunsoye, MD, MSc, PhD, FCCP discloses the following relevant financial relationships:

Advisory Board: Inogen

Consultant: Avalyn, Boehringer Ingelheim

Speaker: Boehringer Ingelheim

Barbara Goldstein, MD does not have any relevant financial relationships to disclose.

Joshua J. Solomon, MD does not have any relevant financial relationships to disclose.

Planner/Reviewer Disclosures:

Meghan Brenner, MA does not have any relevant financial relationships to disclose.

Laniecia Demmer does not have any relevant financial relationships to disclose.

Andrea Harshman, MHA, CHCP, CMP-HC does not have any relevant financial relationships to disclose.

Liudmila Kastsianok, MD, RhMSUS, FACR discloses the following relevant financial relationships:

              Speaker: Boehringer Ingelheim

Zulma Yunt, MD discloses the following relevant financial relationships:

                  Consultant: Johnson and Johnson

                  Speaker: Boehringer Ingelheim

DISCLOSURE OF UNLABELED USE:

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.

Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.

DISCLAIMER:

Disclaimer Statement

National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.